Skip to main content
Top

03-02-2025 | Breast Cancer | Original Article

Locoregional Recurrence-Free Survival in Postmastectomy Breast Cancer: A Comparative Longitudinal Study of Hypofractionated Versus Conventional Fractionated Radiation Therapy

Authors: Suma Susan Meloot, Ciniraj Raveendran, IP Yadev

Published in: Indian Journal of Surgical Oncology

Login to get access

Abstract

The primary objective of our study was to estimate the difference in locoregional recurrence-free survival (LRFS) and investigate the influence of various clinical factors on the risk of locoregional recurrence (LRR) in post-mastectomy breast cancer patients treated with two different radiation fractionations. Data from 317 post-mastectomy patients were retrospectively analyzed. The conventional fractionation schedule was 50 Gy in 25 fractions; the hypofractionated schedule was 42.6 Gy in 16 fractions. LRFS between the two fractionations was estimated and compared. The median LRFS for hypofractionated radiation (n = 194) is 52.5 months (95% CI 23.0–60.0); for conventional fractionated radiation (n = 123) is 60.0 months (95% CI 35.5–60.0; p = 0.008), significant difference at first, but not after further analysis. With univariate cause-specific risk analysis, the hazard ratio (HR) for recurrence with hypofractionated radiation was 1.55 (95% CI 0.76–3.15; p = 0.2). The cause-specific HR for competing events with hypofractionated radiation was 1.04 (95% CI 0.67–1.60; p = 0.9). With multivariable cause-specific hazard analysis, HR for recurrence with hypofractionated radiation vs. conventional is 1.27 (95% CI 0.61–2.65; p = 0.5). Nodal stage is a significant predictor of LRR. Positive margins are associated with higher LRR risk (HR 2.02; p = 0.052). Age, tumor stage, chemotherapy, histology, tumor grade, and hormone receptor status did not significantly influence LRR risk. For post-mastectomy breast cancer patients, hypofractionated radiation treatment is not different from conventional fractionation in achieving locoregional control. Lymph node positivity is a crucial determinant of local recurrence.
Literature
1.
go back to reference Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M et al (2022) Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 66:15–23CrossRefPubMedPubMedCentral Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M et al (2022) Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 66:15–23CrossRefPubMedPubMedCentral
2.
go back to reference Early Breast Cancer Trialists’ Collaborative G, Darby S, McGale P, Correa C, Taylor C, Arriagada R, et al. 2011 Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 378(9804):1707–16 Early Breast Cancer Trialists’ Collaborative G, Darby S, McGale P, Correa C, Taylor C, Arriagada R, et al. 2011 Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 378(9804):1707–16
3.
go back to reference Ebctcg. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. The Lancet. 2014: 383(9935):2127–35 Ebctcg. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. The Lancet. 2014: 383(9935):2127–35
4.
go back to reference Whelan T, MacKenzie R, Julian J, Levine M, Shelley W, Grimard L et al (2002) Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. JNCI J National Cancer Inst 94(15):1143–50CrossRef Whelan T, MacKenzie R, Julian J, Levine M, Shelley W, Grimard L et al (2002) Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. JNCI J National Cancer Inst 94(15):1143–50CrossRef
5.
go back to reference Yang J, Qi SN, Fang H, Song YW, Jin J, Liu YP et al (2021) Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer. Breast 58:72–79CrossRefPubMedPubMedCentral Yang J, Qi SN, Fang H, Song YW, Jin J, Liu YP et al (2021) Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer. Breast 58:72–79CrossRefPubMedPubMedCentral
6.
go back to reference Delaney G, Barton M, Jacob S (2003) Estimation of an optimal radiotherapy utilization rate for breast carcinoma: a review of the evidence. Cancer 98(9):1977–1986CrossRefPubMed Delaney G, Barton M, Jacob S (2003) Estimation of an optimal radiotherapy utilization rate for breast carcinoma: a review of the evidence. Cancer 98(9):1977–1986CrossRefPubMed
7.
go back to reference Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ et al (2013) The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 14(11):1086–1094CrossRefPubMed Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ et al (2013) The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 14(11):1086–1094CrossRefPubMed
8.
go back to reference Wang SL, Fang H, Song YW, Wang WH, Hu C, Liu YP et al (2019) Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised non-inferiority open-label phase 3 trial. Lancet Oncol 20(3):352–360CrossRefPubMed Wang SL, Fang H, Song YW, Wang WH, Hu C, Liu YP et al (2019) Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised non-inferiority open-label phase 3 trial. Lancet Oncol 20(3):352–360CrossRefPubMed
9.
go back to reference Yadav BS, Bansal A, Kuttikat PG, Das D, Gupta A, Dahiya D (2020) Late-term effects of hypofractionated chest wall and regional nodal radiotherapy with two-dimensional technique in patients with breast cancer. Radiat Oncol J 38(2):109–118CrossRefPubMedPubMedCentral Yadav BS, Bansal A, Kuttikat PG, Das D, Gupta A, Dahiya D (2020) Late-term effects of hypofractionated chest wall and regional nodal radiotherapy with two-dimensional technique in patients with breast cancer. Radiat Oncol J 38(2):109–118CrossRefPubMedPubMedCentral
10.
go back to reference Cao L, Kirova YM, Shen KW, Xu C, Chen JY. 2019 Clinical impact of delaying initiation of radiotherapy after definitive surgery or adjuvant chemotherapy in breast cancer patients. I J Radiation Oncology*Biology*Physics. 105(1) Cao L, Kirova YM, Shen KW, Xu C, Chen JY. 2019 Clinical impact of delaying initiation of radiotherapy after definitive surgery or adjuvant chemotherapy in breast cancer patients. I J Radiation Oncology*Biology*Physics. 105(1)
11.
go back to reference Lamm R, Woodward SG, Varshney K, Lyons W, Anne PR, George BJ, Willis AI (2022) A comparison of timely completion of hypofractionated and traditional adjuvant radiation therapy in early-stage breast cancer: evidence of impact on reducing racial and socioeconomic disparities. Surgery 172(1):31–40CrossRefPubMed Lamm R, Woodward SG, Varshney K, Lyons W, Anne PR, George BJ, Willis AI (2022) A comparison of timely completion of hypofractionated and traditional adjuvant radiation therapy in early-stage breast cancer: evidence of impact on reducing racial and socioeconomic disparities. Surgery 172(1):31–40CrossRefPubMed
12.
go back to reference Tovanabutra C, Katanyoo K, Uber P, Chomprasert K, Sukauichai S (2020) Comparison of treatment outcome between hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer. Asian Pac J Cancer Prev 21(1):119–125CrossRefPubMedPubMedCentral Tovanabutra C, Katanyoo K, Uber P, Chomprasert K, Sukauichai S (2020) Comparison of treatment outcome between hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer. Asian Pac J Cancer Prev 21(1):119–125CrossRefPubMedPubMedCentral
13.
go back to reference Bochenek-Cibor J, Georgiew F, Goyal S (2020) A retrospective analysis on safety and effectiveness of hypofractioned post-mastectomy radiotherapy. Breast J 26(2):176–181CrossRefPubMed Bochenek-Cibor J, Georgiew F, Goyal S (2020) A retrospective analysis on safety and effectiveness of hypofractioned post-mastectomy radiotherapy. Breast J 26(2):176–181CrossRefPubMed
14.
go back to reference Pinitpatcharalert A, Chitapanarux I, Euathrongchit J, Tharavichitkul E, Sukthomya V, Lorvidhaya V (2011) A retrospective study comparing hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer. J Med Assoc Thai 94(Suppl 2):S94-102PubMed Pinitpatcharalert A, Chitapanarux I, Euathrongchit J, Tharavichitkul E, Sukthomya V, Lorvidhaya V (2011) A retrospective study comparing hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer. J Med Assoc Thai 94(Suppl 2):S94-102PubMed
15.
go back to reference Liu L, Yang Y, Guo Q, Ren B, Peng Q, Zou L et al (2020) Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review. Radiat Oncol 15(1):17CrossRefPubMedPubMedCentral Liu L, Yang Y, Guo Q, Ren B, Peng Q, Zou L et al (2020) Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review. Radiat Oncol 15(1):17CrossRefPubMedPubMedCentral
16.
go back to reference Raveendran C, Meloot SS, Yadev I (2023) Survival outcomes of post-mastectomy breast cancer patients treated with hypofractionated radiation treatment compared to conventional fractionation - a retrospective cohort study. Gulf J Oncolog 1(42):26–34PubMed Raveendran C, Meloot SS, Yadev I (2023) Survival outcomes of post-mastectomy breast cancer patients treated with hypofractionated radiation treatment compared to conventional fractionation - a retrospective cohort study. Gulf J Oncolog 1(42):26–34PubMed
17.
go back to reference Sun JY, Wu SG, Li S, Li FY, Chen WF, Lin Q, He ZY (2013) Locoregional recurrence of pT3N0M0 breast cancer after mastectomy is not higher than that of pT1-2N0M0: an analysis for radiotherapy. Cancer Sci 104(5):599–603CrossRefPubMedPubMedCentral Sun JY, Wu SG, Li S, Li FY, Chen WF, Lin Q, He ZY (2013) Locoregional recurrence of pT3N0M0 breast cancer after mastectomy is not higher than that of pT1-2N0M0: an analysis for radiotherapy. Cancer Sci 104(5):599–603CrossRefPubMedPubMedCentral
18.
go back to reference Kheradmand AA, Ranjbarnovin N, Khazaeipour Z (2010) Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients. World J Surg Oncol 8(1):30CrossRefPubMedPubMedCentral Kheradmand AA, Ranjbarnovin N, Khazaeipour Z (2010) Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients. World J Surg Oncol 8(1):30CrossRefPubMedPubMedCentral
19.
go back to reference Team RC. 2020 R: A language and environment for statistical computing. 4.0.2 ed. Vienna Austria: R Foundation for Statistical Computing Team RC. 2020 R: A language and environment for statistical computing. 4.0.2 ed. Vienna Austria: R Foundation for Statistical Computing
20.
go back to reference Koulis TA, Nichol AM, Truong PT, Speers C, Gondara L, Tyldesley S et al (2020) Hypofractionated adjuvant radiation therapy is effective for patients with lymph node-positive breast cancer: a population-based analysis. Int J Radiat Oncol Biol Phys 108(5):1150–1158CrossRefPubMed Koulis TA, Nichol AM, Truong PT, Speers C, Gondara L, Tyldesley S et al (2020) Hypofractionated adjuvant radiation therapy is effective for patients with lymph node-positive breast cancer: a population-based analysis. Int J Radiat Oncol Biol Phys 108(5):1150–1158CrossRefPubMed
21.
go back to reference Rosenberger LH, Ren Y, Thomas SM, Greenup RA, Fayanju OM, Hwang ES, Plichta JK (2020) Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough? Breast Cancer Res Treat 179(3):661–670CrossRefPubMed Rosenberger LH, Ren Y, Thomas SM, Greenup RA, Fayanju OM, Hwang ES, Plichta JK (2020) Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough? Breast Cancer Res Treat 179(3):661–670CrossRefPubMed
22.
go back to reference Ebner F, Wockel A, Schwentner L, Blettner M, Janni W, Kreienberg R, Wischnewsky M (2019) Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival? BMC Cancer 19(1):90CrossRefPubMedPubMedCentral Ebner F, Wockel A, Schwentner L, Blettner M, Janni W, Kreienberg R, Wischnewsky M (2019) Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival? BMC Cancer 19(1):90CrossRefPubMedPubMedCentral
23.
go back to reference Abass MO, Gismalla MDA, Alsheikh AA, Elhassan MMA (2018) Axillary lymph node dissection for breast cancer: efficacy and complication in developing countries. J Glob Oncol 4:1–8PubMed Abass MO, Gismalla MDA, Alsheikh AA, Elhassan MMA (2018) Axillary lymph node dissection for breast cancer: efficacy and complication in developing countries. J Glob Oncol 4:1–8PubMed
24.
go back to reference Early Breast Cancer Trialists’ Collaborative Group. Electronic address bocoau Early Breast Cancer Trialists’ Collaborative G. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100,000 women from 86 randomised trials. Lancet. 2023 401(10384):1277–92 Early Breast Cancer Trialists’ Collaborative Group. Electronic address bocoau Early Breast Cancer Trialists’ Collaborative G. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100,000 women from 86 randomised trials. Lancet. 2023 401(10384):1277–92
25.
go back to reference Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337(14):949–55CrossRefPubMed Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337(14):949–55CrossRefPubMed
26.
go back to reference Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A et al (2015) Regional nodal irradiation in early-stage breast cancer. N Engl J Med 373(4):307–316CrossRefPubMedPubMedCentral Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A et al (2015) Regional nodal irradiation in early-stage breast cancer. N Engl J Med 373(4):307–316CrossRefPubMedPubMedCentral
27.
go back to reference Chitapanarux I, Klunklin P, Pinitpatcharalert A, Sripan P, Tharavichitkul E, Nobnop W et al (2019) Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity. Radiat Oncol 14(1):175CrossRefPubMedPubMedCentral Chitapanarux I, Klunklin P, Pinitpatcharalert A, Sripan P, Tharavichitkul E, Nobnop W et al (2019) Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity. Radiat Oncol 14(1):175CrossRefPubMedPubMedCentral
28.
go back to reference Benolken MM, McLaughlin S, Piltin M, Mrdutt M, Li Z, Jakub JW (2023) Lymph node positivity of axillary reverse mapping lymph nodes at the time of axillary lymph node dissection: two-site prospective trial. Ann Surg Oncol 30(10):6042–6049CrossRefPubMed Benolken MM, McLaughlin S, Piltin M, Mrdutt M, Li Z, Jakub JW (2023) Lymph node positivity of axillary reverse mapping lymph nodes at the time of axillary lymph node dissection: two-site prospective trial. Ann Surg Oncol 30(10):6042–6049CrossRefPubMed
29.
go back to reference Harahap WA, Nindrea RD (2019) Prognostic factors of local-regional recurrence in patients with operable breast cancer in Asia: a meta-analysis. Open Access Maced J Med Sci 7(4):690–695CrossRefPubMedPubMedCentral Harahap WA, Nindrea RD (2019) Prognostic factors of local-regional recurrence in patients with operable breast cancer in Asia: a meta-analysis. Open Access Maced J Med Sci 7(4):690–695CrossRefPubMedPubMedCentral
30.
go back to reference Shah C, Hobbs BP, Vicini F, Al-Hilli Z, Manyam BV, Verma V et al (2020) The diminishing impact of margin definitions and width on local recurrence rates following breast-conserving therapy for early-stage invasive cancer: a meta-analysis. Ann Surg Oncol 27(12):4628–4636CrossRefPubMed Shah C, Hobbs BP, Vicini F, Al-Hilli Z, Manyam BV, Verma V et al (2020) The diminishing impact of margin definitions and width on local recurrence rates following breast-conserving therapy for early-stage invasive cancer: a meta-analysis. Ann Surg Oncol 27(12):4628–4636CrossRefPubMed
31.
go back to reference Yoon TI, Lee JW, Lee SB, Sohn G, Kim J, Chung IY et al (2018) No association of positive superficial and/or deep margins with local recurrence in invasive breast cancer treated with breast-conserving surgery. Cancer Res Treat 50(1):275–282CrossRefPubMed Yoon TI, Lee JW, Lee SB, Sohn G, Kim J, Chung IY et al (2018) No association of positive superficial and/or deep margins with local recurrence in invasive breast cancer treated with breast-conserving surgery. Cancer Res Treat 50(1):275–282CrossRefPubMed
Metadata
Title
Locoregional Recurrence-Free Survival in Postmastectomy Breast Cancer: A Comparative Longitudinal Study of Hypofractionated Versus Conventional Fractionated Radiation Therapy
Authors
Suma Susan Meloot
Ciniraj Raveendran
IP Yadev
Publication date
03-02-2025
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-025-02216-9
SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

  • Webinar | 06-02-2024 | 20:00 (CET)

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
Watch now